{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:12Z","timestamp":1787027052642,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Drug resistance affects 30% of patients with epilepsy. Cannabidiol (CBD) decreases the expression of drug-resistant seizures in specific syndromes. However, it is unknown if CBD prevents the development of drug-resistant condition in epilepsy. This research was conducted to investigate if subchronic administration of CBD with sodium channel blockers modifies the mortality associated with clonic-tonic seizures and the development of the drug-resistant phenotype induced by subchronic administration of 3-mercaptopropionic acid (3-MP) in rats. These effects were compared with those elicited by antiseizure medications acting on the GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors. Male Wistar rats were used to evaluate CBD combined with different antiseizure medications (phenobarbital, diazepam, valproic acid, lamotrigine and oxcarbazepine) during the repetitive administration of 3-MP. The mortality rate and development of drug-resistant seizures were estimated. Computational experiments explored interactions between CBD and sodium channel blockers in the NaV1.7 receptor. Subchronic administration of CBD alone did not modify neither the mortality rate nor the development of drug-resistant seizures. CBD combined with phenobarbital or diazepam reduced the mortality rate and prevalence of drug-resistant seizures. In contrast, coadministration of CBD with valproic acid or lamotrigine did not modify neither the mortality rate nor the expression of drug-resistant seizures. Contrariwise, combining CBD with oxcarbazepine at ED\n                    <jats:sub>50<\/jats:sub>\n                    increases the incidence of drug-resistant seizures. Computational experiments suggested that CBD acting on NaV1.7 interferes with the action of sodium channel blockers and precludes their inhibitory effects. Our results indicate that repeated administration of CBD with GABAergic antiseizure medications, but not sodium channel blockers, decreases the mortality and prevents the development of the drug-resistant phenotype induced by repeatedly provoked severe seizures.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2025.1644018","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:28:33Z","timestamp":1758259713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical model"],"prefix":"10.3389","volume":"16","author":[{"given":"Monserrat","family":"Fuentes-Mejia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano J.","family":"Fallico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Talevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Gavernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Orozco-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.ijo.0803137","article-title":"The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat","volume":"30","author":"Abbott","year":"2006","journal-title":"Int. J. Obes."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1111\/bph.15181","article-title":"Interactions between cannabidiol and \u03949 -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome","volume":"177","author":"Anderson","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/s0962728600029389","article-title":"The welfare impact of gavaging laboratory rats","volume":"14","author":"Bonnichsen","year":"2005","journal-title":"Anim. Welf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.3390\/ijms25126751","article-title":"Chronic treatment with oxcarbazepine attenuates its anticonvulsant effect in the maximal electroshock model in mice","volume":"25","author":"Borowicz-Reutt","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"612624","DOI":"10.3389\/fnbeh.2020.612624","article-title":"Behavioral and molecular effects induced by cannabidiol and valproate administration in the GASH\/sal model of acute audiogenic seizures","volume":"14","author":"Cabral-Pereira","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e00727","DOI":"10.1002\/brb3.727","article-title":"Effect of lamotrigine on seizure development in a rat pentylenetetrazole kindling model","volume":"7","author":"Chen","year":"2017","journal-title":"Brain Behav."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eplepsyres.2016.10.012","article-title":"New model of pharmacoresistant seizures induced by 3-mercaptopropionic acid in mice","volume":"129","author":"Enrique","year":"2017","journal-title":"Epilepsy Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.seizure.2021.04.008","article-title":"Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures","volume":"90","author":"Fr\u00edas-Soria","year":"2021","journal-title":"Seizure"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/epi4.12954","article-title":"Development of a novel dosing paradigm to model diazepam rescue therapy in preclinical seizure and epilepsy models","volume":"9","author":"Guignet","year":"2024","journal-title":"Epilepsia Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug\u2010resistant epilepsy in Tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Nav channels through two distinct binding sites","volume":"14","author":"Huang","year":"","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2309773120","DOI":"10.1073\/pnas.2309773120","article-title":"Dual-pocket inhibition of Nav channels by the antiepileptic drug lamotrigine","volume":"120","author":"Huang","year":"","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B17","first-page":"141","article-title":"Certain aspects of pharmacological profiles of chlordiazepoxide and diazepam","volume":"12","author":"Jindal","year":"1968","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/bph.14202","article-title":"Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model","volume":"175","author":"Khan","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/epi.14190","article-title":"Lamotrigine-resistant corneal-kindled mice: a model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery","volume":"59","author":"Koneval","year":"2018","journal-title":"Epilepsia"},{"key":"B21","first-page":"255","article-title":"Treatment of seizures associated with lennox-gastaut and dravet syndromes: a focus on cannabidiol oral solution","volume":"44","author":"Lazaridis","year":"2019","journal-title":"P T"},{"key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00007691-200402000-00010","article-title":"Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy","volume":"26","author":"Lazarowski","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/0006-2952(79)90443-X","article-title":"3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the \u03b3-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine","volume":"28","author":"L\u00f6scher","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/epi.12610","article-title":"The case for medical marijuana in epilepsy","volume":"55","author":"Maa","year":"2014","journal-title":"Epilepsia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3390\/biomedicines11123237","article-title":"Cannabidiol modifies the glutamate over-release in brain tissue of patients and rats with epilepsy: a pilot study","volume":"11","author":"Mart\u00ednez-Aguirre","year":"2023","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1627465","DOI":"10.3389\/fphar.2025.1627465","article-title":"Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy","volume":"16","author":"Martinez-Rojas","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1528-1157.1986.tb03530.x","article-title":"Differential antiepileptic sensitivity between cortical sites in the rat","volume":"27","author":"Moss","year":"1986","journal-title":"Epilepsia"},{"key":"B28","volume-title":"Fitting models to biological data using linear and nonlinear regression A practical guide to curve fitting contents at a glance","author":"Motulsky","year":"2003"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00688242","article-title":"Neuronal lesions in mercaptopropionic acid-induced status epilepticus","volume":"77","author":"O\u2019Connell","year":"1988","journal-title":"Acta Neuropathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","author":"Patra","year":"2019","journal-title":"Epilepsia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107659","DOI":"10.1016\/j.yebeh.2020.107659","article-title":"Noninvasive transcranial focal stimulation affects the convulsive seizure-induced P-glycoprotein expression and function in rats","volume":"115","author":"P\u00e9rez-P\u00e9rez","year":"2021","journal-title":"Epilepsy Behav."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0306-4522(98)00142-0","article-title":"Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats","volume":"87","author":"Pierce","year":"1998","journal-title":"Neuroscience"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/j.1499-1654.2000.001514.x","article-title":"Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy","volume":"41","author":"Postma","year":"2000","journal-title":"Epilepsia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"114240","DOI":"10.1016\/j.expneurol.2022.114240","article-title":"Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures","volume":"359","author":"Reddy","year":"2023","journal-title":"Exp. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.2217\/NNM.15.173","article-title":"Phenytoin carried by silica core iron oxide nanoparticles reduces the expression of pharmacoresistant seizures in rats","volume":"10","author":"Rosillo-de la Torre","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","article-title":"Cannabidiol claims and misconceptions","volume":"38","author":"Russo","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-0040-1701694","article-title":"Changing landscape of Dravet syndrome management: an overview","volume":"51","author":"Samanta","year":"2020","journal-title":"Neuropediatrics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"115007","DOI":"10.1016\/j.physbeh.2025.115007","article-title":"Reduction in prepulse inhibition following acute stress in male and female wistar rats","volume":"299","author":"Santos-Carrasco","year":"2025","journal-title":"Physiol. Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1157.1982.tb05426.x","volume-title":"Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats","author":"Shenoy","year":"1982"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/molecules24081459","article-title":"Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials","volume":"24","author":"Silvestro","year":"2019","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0031-9384(94)90089-2","article-title":"The interaction between prenatal stress and neonatal handling on nociceptive response latencies in male and female rats","volume":"55","author":"Smythe","year":"1994","journal-title":"Physiol. Behav."},{"key":"B43","doi-asserted-by":"publisher","first-page":"107733","DOI":"10.1016\/j.neuropharm.2019.107733","article-title":"Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: pharmacodynamic and pharmacokinetic studies","volume":"158","author":"Soca\u0142a","year":"2019","journal-title":"Neuropharmacology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/epi.12234","article-title":"Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy","volume":"54","author":"Srivastava","year":"2013","journal-title":"Epilepsia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/BF00687889","article-title":"Substantia nigra lesions in mercaptopropionic acid induced status epilepticus: a light and electron microscopic study","volume":"77","author":"Towfighi","year":"1989","journal-title":"Acta Neuropathol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1535-7511.2006.00106.x","article-title":"Update on the role of substantia nigra pars reticulata in the regulation of seizures","volume":"6","author":"Vel\u00ed\u0161kov\u00e1","year":"2006","journal-title":"Epilepsy Curr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0014-2999(94)90787-0","article-title":"Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures","volume":"271","author":"Wamil","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Nav1.7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr. Drug Metab."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1644018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:28:35Z","timestamp":1758259715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1644018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":51,"alternative-id":["10.3389\/fphar.2025.1644018"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1644018","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1644018"}}